"10.1371_journal.pone.0091550","plos one","2014-03-13T00:00:00Z","Rashmi Jalah; Viraj Kulkarni; Vainav Patel; Margherita Rosati; Candido Alicea; Jenifer Bear; Lei Yu; Yongjun Guan; Xiaoying Shen; Georgia D Tomaras; Celia LaBranche; David C Montefiori; Rajasekhar Prattipati; Abraham Pinter; Julian Bess; Jeffrey D Lifson; Steven G Reed; Niranjan Y Sardesai; David J Venzon; Antonio Valentin; George N Pavlakis; Barbara K Felber","Human Retrovirus Pathogenesis Section, National Cancer Institute, Frederick, Maryland, United States of America; Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America; Institute of Human Virology, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America; Duke Human Vaccine Institute and Departments of Surgery and Immunology, Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, United States of America; Department of Surgery, Duke University Medical Center, Durham, North Carolina, United States of America; Public Health Research Institute, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, United States of America; AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America; Infectious Disease Research Institute, Seattle, Washington, United States of America; Inovio Pharmaceuticals, Inc., Blue Bell, Pennsylvania, United States of America; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America","Conceived and designed the experiments: AV GNP BKF. Performed the experiments: RJ VK VP MR CA JB LY YG XS GDT CL DCM. Analyzed the data: RJ MR YG XS GDT CL DCM DJV AV GNP BKF. Contributed reagents/materials/analysis tools: RP AP JBJr JDL SGR NYS GNP BKF. Wrote the paper: AV GNP BKF.","I have read the journals policy and have the following conflicts, GNP and BKF are inventors on US Government-owned patents and patent applications related to DNA vaccines and gene expression optimization that have been licensed to several companies. There are no further patents, products in development or marketed products to declare. NYS is a full time employee of Inovio Pharmaceuticals and as such receive compensation in the form of salary and stock options. SR is a founder and shareholder in Immune Design Corp. which has certain rights to the adjuvant used in this study under license agreement with IDRI. This does not alter our adherence to all PLoS Ones policies on sharing data and materials.","2014","03","Rashmi Jalah","RJ",22,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
